JRX is a skin delivery system and specialty biochemistry technology company. We are focused on developing and commercializing our DermXTM MegasphereTM Delivery System - a novel and patented dermal/transdermal delivery system technology platform that has been independently proven to allow high payloads of large molecular weight molecules to penetrate into and through human skin.

The company's DermXTM MegasphereTM Delivery System has been proven three times over:

  1. In the Labin vitro; using Franz Cell testing methodologies,
  2. In the Clinicin vivo; topical anti-aging products tested at several independent skin
        care testing laboratories, and
  3. In the Market – millions of dollars of sales of numerous skincare, Over-the-Counter and
        prescription products sold through a multitude of distribution channels.

JRX Biotech believes that by delivering "more, deeper" – this translates to a "better, faster" product. Please contact us if you believe the same: info@jrxbiotech.com.